/Cboe%20Global%20Markets%20Inc_%20office%20sign-by%20JHVEPhoto%20via%20Shutterstock.jpg)
Cboe Global Markets, Inc. (CBOE) is a leading global exchange operator and financial technology firm, headquartered in Chicago and employing around 1,650 people. With a market cap of $23.6 billion, it spans trading venues across North America, Europe, and Asia-Pacific.
Companies with a market value of $10 billion or more are classified as “large-cap stocks,” Cboe Global holds its place in this category. It leads the U.S. options market and is the originator of the VIX volatility index, giving it a unique edge in volatility-driven trading. Its consistent innovation, regulatory expertise, and scale position it as a key player in capital markets infrastructure, capable of capitalizing on both market volatility and long-term trading trends.
Cboe Global shares are currently trading 3.6% below its 52-week high of $236.02, which they touched recently on May 8. The stock has climbed 3.6% over the past three months, underperforming the broader Nasdaq Composite’s ($NASX) 11.7% rise over the same time frame.
However, on a year-to-date basis, CBOE has delivered a standout performance, surging 16.5% and handily outperforming the Nasdaq’s modest 1.2% return. The outperformance extends over the longer horizon as well, with CBOE boasting a 34.4% gain over the past 52 weeks, far exceeding the Nasdaq’s 9.4% rise during the same period.
Since July last year, CBOE has remained above its 200-day moving average and has mostly traded over its 50-day moving average since early April.
On May 2, shares of Cboe Global Markets rose over 2% following the release of its Q1 results, which exceeded expectations on both earnings and revenue. The company reported adjusted EPS of $2.50, surpassing consensus estimates by 5.9%, while adjusted revenue came in at $565.2 million, topping forecasts by 1.5%. It upgraded full-year guidance, with revenue growth now projected in the mid-to-high single-digit range, thanks to continued investment in tech platforms, global expansion, and Data Vantage.
CBOE’s rival, CME Group Inc. (CME), has outperformed the stock and gained 38.5% over the past 52 weeks and 17.2% in 2025.
Analysts maintain a cautious outlook on its prospects. CBOE has a consensus rating of “Hold” from the 17 analysts covering the stock and is currently trading above its mean price target of $225.
